Katherine xu william blair
WebbKatherine Xu: William Blair: Keay Nakae: Chardan: Madhu Kumar: B. Riley FBR: Call transcript. Due to licensing restrictions, you must log in to view earnings call transcripts. Log in. Operator. Good afternoon, ladies and gentlemen, and welcome to the Arbutus Biopharma Second Quarter 2024 Financial Results and Corporate Update Conference … Webbför 2 dagar sedan · 300 N. Washington St., Suite 200, Falls Church, VA 22046, USA. Phone 703.538.7600 – Toll free 888.838.5578
Katherine xu william blair
Did you know?
WebbShe serves as a Board Member at Equillium. She has been with the firm since May 2024. Dr. Xu currently serves on the board of Equillium (NASDAQ: EQ). Prior to joining Decheng Capital, Dr. Xu was a Partner, Senior Biotechnology Analyst, and Co-Group Head of the Biopharmaceutical Equity Research team at William Blair & Company based in New … Webb9 feb. 2024 · Dr. Y. Katherine Xu is a partner at Decheng Capital and has been with the firm since May 2024. Before joining Decheng, Dr. Xu was Partner, Senior …
WebbDr. Xu previously held the position of Vice President-Investment Banking at Petkevich & Partners LLC, Analyst at Credit Suisse Securities (USA) LLC (Broker), Research … Webb9 feb. 2024 · Dr. Y. Katherine Xu is a partner at Decheng Capital and has been with the firm since May 2024. Prior to joining Decheng, Dr. Xu was Partner, Senior …
Webb3 aug. 2012 · Edward M. Fitzgerald - Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Treasurer Analysts Matthew Harrison - UBS Investment Bank, Research Division Y. Katherine... WebbDr. Y. Katherine Xu is an expert in the fields of biotechnology, financial analysis, equity research, investments, and corporate finance. She is currently a partner at Decheng …
Webb3 okt. 2014 · Dr. Y. Katherine Xu, Analyst with William Blair & Co., says Ariad Pharmaceuticals, Inc. (ARIA) has the potential for 100% upside from current levels. She says the stock is being ignored by ...
Webb25 feb. 2013 · Y. Katherine Xu - William Blair & Company L.L.C., Research Division. Megan McCloskey - MLV & Co LLC, Research Division. Operator. Good day, everyone, … hujan malam iniWebb26 maj 2011 · Y. Katherine Xu Joins William Blair & Company, Launches Coverage of Biotechnology Companies Published: May 26, 2011 CHICAGO, May 26, … hujan lebat di malaysiaWebb9 feb. 2024 · Dr. Y. Katherine Xu is a partner at Decheng Capital and has been with the firm since May 2024. Prior to joining Decheng, Dr. Xu was Partner, Senior Biotechnology Analyst and Co-Group Head of the Biopharmaceutical Equity Research team at William Blair & Company based in New York. hujan malam hariWebb30 okt. 2024 · Katherine Xu William Blair & Company L.L.C., Research Division - Co-Group Head of Biopharma Equity Research, Partner & Biotechnology Analyst Marc Alan Frahm Cowen and Company, LLC, Research Division - VP Matthew Kelsey Harrison Morgan Stanley, Research Division - Executive Director hujan masih air dan dia masih milik orang lain artinyaWebbKatherine Xu is a Partner, Equity Research Analyst - Therapeutics at William Blair based in Chicago, Illinois. Previously, Katherine was a Biotech nology and Biopharmaceuticals at Wedbush and also held positions at Pacific Growth Equities. hujan malam menambah resahWebbKatherine Xu: William Blair: Call transcript. Due to licensing restrictions, you must log in to view earnings call transcripts. Log in. Operator. Good afternoon, ladies and gentlemen and welcome to the aTyr Pharma's fourth quarter and full 2024 conference call. hujan lirik sudirmanWebb9 feb. 2024 · Dr. Y. Katherine Xu is a partner at Decheng Capital and has been with the firm since May 2024. Prior to joining Decheng, Dr. Xu was Partner, Senior … hujan magelang